In 2021, . In this course, you will be introduced to diabetes as a prevalent healthcare concern rising in abundance. Consistently high blood glucose levels can cause damage throughout the body, significantly impacting the heart, blood vessels, kidneys, nerves, teeth and eyes. This course will have a specific emphasis on complications affecting the eyes, including exploring how eye problems can be avoided, diagnosed, managed and treated, with a focus on the role of the pharmacist in this.
By the end of this course, you will be able to:
- Identify signs and symptoms of diabetic eye complications and appropriately refer patients
- Counsel patients about the importance of medication adherence, the need to control blood sugar levels, diabetic eye problems, and the value of eye screening
- to improve patient therapeutic outcomes
- Educate people living with diabetes about the risk of eye disease, strategies to prevent eye complications and the fact that vision may not be affected until late in the disease
This course should take approximately 4 hours to complete.
Before we begin, have a go at completing the baseline quiz. This quiz aims solely to measure your baseline understanding before taking the course. There will be another quiz at the end of the course so you can compare scores and check your progress. Please note that you can only attempt this quiz once.
This CPD course is supported by Novartis International AG. The views expressed in this course are those of the authors and contributors and not necessarily those of Novartis International AG. Materials throughout are sourced from:
Diabetic Retinopathy and Diabetic Macular Edema Apr 19, 2021 FUSE MLR ID: 119478 [Powerpoint Presentation 16/06/22]
Diabetic Eye Complications Acknowledgements
Author: Pauline Roberts and Roger Roberts
Reviewers: Manjula Halai, Tunde Peto, Chiko Savieli and Racheal Yoon
Content: Prof Tunde Peto, Professor of Clinical Ophthalmology and Novartis International AG - Training [source- Diabetic Retinopathy and Diabetic Macular Edema Apr 19, 2021 FUSE MLR ID: 119478 [Powerpoint Presentation 16/06/22]] for providing images and illustrations used in this course.
The views expressed in this course are those of the authors and contributors and not necessarily those of Novartis International AG, who supported the development of this CPD.
Published: June 2022
Review date: May 2025